Immune tolerance induction with human-cl rhFVIII in patients with severe haemophilia A and inhibitors

被引：0
|
作者：
Hall, G. [1 ]
Bhatnagar, N. [1 ]
Khair, K. [2 ]
Wilkinson, A. [1 ]
Belyanskaya, L. [3 ]
Liesner, R. [2 ]
机构：
[1] Oxford Univ Hosp NHS Fdn Trust, Childrens Hosp Oxford, Oxford Haemophilia & Thrombosis Comprehens Care C, Oxford, England
[2] Great Ormond St Hosp Children NHS Fdn Trust, Haemophilia Comprehens Care Ctr, London, England
[3] Octapharma AG, Lachen, Switzerland
来源：
HAEMOPHILIA | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P115
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [1] INDIVIDUALIZED PROPHYLAXIS WITH HUMAN-CL RHFVIII IN ADULT PATIENTS WITH SEVERE HAEMOPHILIA A
    Tiede, Andreas
    Lissitchkov, Toshko
    Walter, Olaf
    Bichler, Johann
    Yotov, Gancho
    Knaub, Sigurd
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E48 - E49
  • [2] IMMUNE TOLERANCE INDUCTION RESCUE (ITI-R) WITH HUMAN-CL RHFVIII IN HEMOPHILIA A PATIENTS AND HIGH-TITRE INHIBITORS
    Zanon, E.
    Pasca, S.
    Pollio, B.
    Ricca, I.
    Marino, R.
    [J]. HAEMATOLOGICA, 2019, 104 : 19 - 19
  • [3] Efficacy and safety of Nuwiq® (human-cl rhFVIII) in patients with severe haemophilia A undergoing surgical procedures
    Zozulya, N.
    Kessler, C. M.
    Klukowska, A.
    von Depka, M.
    Hampton, K.
    Hay, C. R. M.
    Jansen, M.
    Bichler, J.
    Knaub, S.
    Rangarajan, S.
    [J]. HAEMOPHILIA, 2018, 24 (01) : 70 - 76
  • [4] Efficacy and safety of prophylactic treatment with Human-cl rhFVIII in previously treated patients with severe haemophilia A
    Lissitchkov, T.
    Hampton, K.
    Von Depka, M.
    Rangarajan, S.
    Hay, C.
    Tuddenham, E. D. G.
    Collins, P. W.
    Holstein, K.
    Huth-Kuehne, A.
    Pabinger, I.
    Bichler, J.
    Knaub, S.
    Oldenburg, J.
    [J]. HAEMOPHILIA, 2012, 18 (05) : 828 - 828
  • [5] Efficacy and safety of on-demand treatment with Human-cl rhFVIII in previously treated patients with severe haemophilia A
    Valentino, L. A.
    Knaub, S.
    Powell, J.
    Tiede, A.
    Bichler, J.
    Manco-Johnson, M.
    [J]. HAEMOPHILIA, 2013, 19 (03) : 470 - 470
  • [6] Pharmacokinetics and efficacy of on-demand treatment with human-cl rhFVIII in previously treated patients with severe haemophilia A
    Lissitchkov, T.
    Tiede, A.
    Valentino, L.
    Powell, J.
    Klamroth, R.
    Quon, D.
    Kessler, C.
    Philipp, C.
    Bichler, J.
    Knaub, S.
    Manco-Johnson, M.
    [J]. HAEMOPHILIA, 2012, 18 : 150 - 150
  • [7] Efficacy and safety of on-demand treatment with Human-cl rhFVIII in previously treated patients with severe haemophilia A
    Walter, O.
    Tiede, A.
    Lissitchkov, T.
    Klamroth, R.
    Valentino, L.
    Powell, J.
    Kessler, C.
    Quon, D.
    Philipp, C.
    Bichler, J.
    Knaub, S.
    Manco-Johnson, M.
    [J]. HAEMOPHILIA, 2013, 19 : 73 - 73
  • [8] Study On Personalized Prophylaxis with Human-Cl RHFVIII in Adult Patients with Severe Haemophilia A - Interim Data On 30 Patients
    Klamroth, R.
    Lissitchkov, T.
    Rusen, L.
    Walter, O.
    Knaub, S.
    Bichler, J.
    Marin, I.
    Tiede, A.
    [J]. HAEMOPHILIA, 2015, 21 : 38 - 39
  • [9] PUPs with severe haemophilia A - a GCP study evaluating the immunogenicity, efficacy and safety of Human-cl rhFVIII
    Liesner, R.
    Jansen, M.
    Kavardakova, N.
    Abashidze, M.
    Knaub, S.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 598 - 599
  • [10] PK-guided personalized prophylaxis with Nuwiq® (human-cl rhFVIII) in adults with severe haemophilia A
    Lissitchkov, T.
    Rusen, L.
    Georgiev, P.
    Windyga, J.
    Klamroth, R.
    Gercheva, L.
    Nemes, L.
    Tiede, A.
    Bichler, J.
    Knaub, S.
    Belyanskaya, L.
    Walter, O.
    Pasi, K. J.
    [J]. HAEMOPHILIA, 2017, 23 (05) : 697 - 704
12345